Women’s skin study shows distinct chemical changes in response to psychological stress

The ac­tivist share­hold­er El­liott In­vest­ment Man­age­ment has built a stake in the con­tract man­u­fac­tur­er Catal­ent, ac­cord­ing to a re­port from The Wall Street Jour­nal.  The

En­cellin raised $9.9 mil­lion to join the bur­geon­ing type 1 di­a­betes space with its own cell re­place­ment ther­a­py and first-in-hu­man da­ta ex­pect­ed next year. The